Health
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial – The Lancet
CoronaVac was well tolerated and safe and induced humoral responses in children andadolescents aged 3–17 years. Neutralising…
We use cookies to help provide and enhance our service and tailor content and ads. To update your cookie settings, please visit the Cookie Preference Center for this site.Copyright © 2021 Elsevier Inc. except certain content provided by third parties. The…
Continue Reading
-
Noosa News16 hours agoProtest calls for shark net removal
-
General15 hours agoThree youths in police custody after fire at Ashley Youth Detention Centre in northern Tasmania
-
Noosa News18 hours agoNew playground equipment encourages children to learn through ‘risky play’
-
Noosa News8 hours agoYork family honours late son with tractor museum to fund cancer research